Shareholder rights law firm Robbins LLP is investigating whether certain officers and directors of Sage Therapeutics, Inc. (NASDAQ: SAGE) breached their fiduciary duties to shareholders. Sage Therapeutics is a clinical-stage biopharmaceutical company that develops and commercializes medicines to treat central nervous system (CNS) disorders.

If you suffered a loss as a result of Sage Therapeutics' misconduct, click here.

Sage Therapeutics, Inc. (SAGE) Shareholders Have Legal Options

Contact us to learn more: Leonid Kandinov (800) 350-6003 LKandinov@robbinsllp.com Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.

Attorney Advertising. Past results do not guarantee a similar outcome.

Leonid Kandinov Robbins LLP 5040 Shoreham Place San Diego, CA 92122 LKandinov@robbinsllp.com (619) 525-3990 or Toll Free (800) 350-6003 www.robbinsllp.com

Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Sage Therapeutics Charts.
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Sage Therapeutics Charts.